Enlivex Therapeutics position history
The shares of Enlivex Therapeutics that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 457,797 shares, $4.5M, 0.01% of portfolio
- 2021 Q4: 349,308 shares, $2.2M, <0.01% of portfolio, Reduce −23.7%
- 2022 Q1: 434,343 shares, $2.4M, 0.01% of portfolio, Add +24.3%
- 2022 Q2: 331,001 shares, $1.7M, <0.01% of portfolio, Reduce −23.8%
- 2022 Q3: not held, Exit
- 2022 Q4: not held
- 2023 Q1: not held
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: 628,310 shares, $584K, <0.01% of portfolio, New
- 2026 Q2: 2,382,731 shares, $1.3M, <0.01% of portfolio, Add +279.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|